journal article·2022-09-09Open access

Tissue-Engineered Models of the Human Brain: State-of-the-Art Analysis and Challenges

Giulia Tarricone, Irene Carmagnola, Valeria Chiono

Abstract

Neurological disorders affect billions of people across the world, making the discovery of effective treatments an important challenge. The evaluation of drug efficacy is further complicated because of the lack of in vitro models able to reproduce the complexity of the human brain structure and functions. Some limitations of 2D preclinical models of the human brain have been overcome by the use of 3D cultures such as cell spheroids, organoids and organs-on-chip. However, one of the most promising approaches for mimicking not only cell structure, but also brain architecture, is currently represented by tissue-engineered brain models. Both conventional (particularly electrospinning and salt leaching) and unconventional (particularly bioprinting) techniques have been exploited, making use of natural polymers or combinations between natural and synthetic polymers. Moreover, the use of induced pluripotent stem cells (iPSCs) has allowed the co-culture of different human brain cells (neurons, astrocytes, oligodendrocytes, microglia), helping towards approaching the central nervous system complexity. In this review article, we explain the importance of in vitro brain modeling, and present the main in vitro brain models developed to date, with a special focus on the most recent advancements in tissue-engineered brain models making use of iPSCs. Finally, we critically discuss achievements, main challenges and future perspectives.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Pluripotent Stem Cells Research · Neuroscience and Neural Engineering

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Corso Duca Degli Abruzzi 24, 10129 Turin, Italy

PolitoBioMedLab, Politecnico di Torino, Corso Duca Degli Abruzzi 24, 10129 Turin, Italy

Interuniversity Center for the Promotion of the 3Rs Principle in Teaching and Research, Centro 3R, 56122 Pisa, Italy

Nanobiointeractions & Nanodiagnostics, Istituto Italiano di Tecnologia (IIT), Via Morego 30, 16163 Genova, Italy

Department of Chemistry and Industrial Chemistry, University of Genova, Via Dodecaneso 31, 16146 Genova, Italy

References (100+)

Show source-provided references
1. Glial Tissue Mechanics and Mechanosensing by Glial Cells10.3389/fncel.2018.00025 ↗
2. Generic aspects of complexity in brain imaging data and other biological systems10.1016/j.neuroimage.2009.05.032 ↗
3. Chemical and electrical synapses perform complementary roles in the synchronization of interneuronal networks10.1073/pnas.0406343101 ↗
4. Neocortical glial cell numbers in human brains10.1016/j.neurobiolaging.2007.04.013 ↗
5. Polydendrocytes (NG2 cells): Multifunctional cells with lineage plasticity10.1038/nrn2495 ↗
6. NG2 cells (polydendrocytes) in brain physiology and repair
7. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination10.1038/s41467-019-11638-3 ↗
8. Perspective The Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease10.1016/j.neuron.2008.10.013 ↗
9. Evolution of increased glia-neuron ratios in the human frontal cortex10.1073/pnas.0605843103 ↗
10. Astrocytes in Neuropathologies Affecting the Frontal Cortex10.3389/fncel.2019.00044 ↗
11. Daneman, R., and Prat, A. (2015). The Blood-Brain Barrier. Cold Spring Harb. Perspect. Biol., 7.10.1101/cshperspect.a020412 ↗
12. Myelination of the nervous system: Mechanisms and functions10.1146/annurev-cellbio-100913-013101 ↗
13. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity10.1038/nature11007 ↗
14. Motor skill learning requires active central myelination10.1126/science.1254960 ↗
15. Immune function of microglia10.1002/glia.1106 ↗
16. Synaptic pruning by microglia is necessary for normal brain development10.1126/science.1202529 ↗
17. A novel microglial subset plays a key role in myelinogenesis in developing brain10.15252/embj.201696056 ↗
18. Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix10.1007/BF00190136 ↗
19. Extracellular matrix and traumatic brain injury10.1002/jnr.24151 ↗
20. Tissue mechanics regulate brain development, homeostasis and disease10.1242/jcs.191742 ↗
21. Deng, M., Lin, J., Nowsheen, S., Liu, T., Zhao, Y., Villalta, P.W., Sicard, D., Tschumperlin, D.J., Lee, S.B., and Kim, J.J. (2020). Extracellular matrix stiffness determines DNA repair efficiency and cellular sensitivity to genotoxic agents. Sci. Adv., 6.10.1126/sciadv.abb2630 ↗
22. Extracellular matrix of the central nervous system: From neglect to challenge10.1007/s00418-008-0485-9 ↗
23. Vecino, E., and Kwok, J.C.F. (2016). The Extracellular Matrix in the Nervous System: The Good and the Bad Aspects. Composition and Function of the Extracellular Matrix in the Human Body, IntechOpen.10.5772/62527 ↗
24. The brain’s extracellular matrix and its role in synaptic plasticity10.1007/978-3-7091-0932-8_7 ↗
25. Extracellular matrix functions during neuronal migration and lamination in the mammalian central nervous system10.1002/dneu.20946 ↗
26. Mechanics in neuronal development and repair10.1146/annurev-bioeng-071811-150045 ↗
27. Modulation of the immune response by extracellular matrix proteins10.1007/s00005-006-0043-x ↗
28. Neurologic Defects and Selective Disruption of Basement Membranes in Mice Lacking Entactin-1/Nidogen-110.1097/01.LAB.0000042240.52093.0F ↗
29. Vascular basement membranes as pathways for the passage of fluid into and out of the brain10.1007/s00401-016-1555-z ↗
30. Structure and biological activity of basement membrane proteins10.1111/j.1432-1033.1989.tb14673.x ↗
31. Perineuronal net formation and structure in aggrecan knockout mice10.1016/j.neuroscience.2010.08.032 ↗
32. Damaged Neocortical Perineuronal Nets Due to Experimental Focal Cerebral Ischemia in Mice, Rats and Sheep10.3389/fnint.2017.00015 ↗
33. Protective Properties of Neural Extracellular Matrix10.1007/s12035-014-8990-4 ↗
34. Perineuronal nets potentially protect against oxidative stress10.1016/j.expneurol.2004.04.017 ↗
35. Brain matrix: Structure, turnover and necessity10.1042/BST0350656 ↗
36. Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance10.3389/fnins.2019.00521 ↗
37. Basement membrane and blood-brain barrier10.1136/svn-2018-000198 ↗
38. Endothelial Cell-to-Cell Junctions: Molecular Organization and Role in Vascular Homeostasis10.1152/physrev.00035.2003 ↗
39. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain10.1007/s40263-016-0405-9 ↗
40. Blood-brain barrier dysfunction in ischemic stroke: Targeting tight junctions and transporters for vascular protection10.1152/ajpcell.00095.2018 ↗
41. Astrocyte barriers to neurotoxic inflammation10.1038/nrn3898 ↗
42. Astrocytes in Alzheimer’s disease and other age-associated dementias: A supporting player with a central role10.1111/nan.12338 ↗
43. Involvement of Astrocytes in Alzheimer’s Disease from a Neuroinflammatory and Oxidative Stress Perspective10.3389/fnmol.2017.00427 ↗
44. Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington’s disease model mice10.1038/nn.3691 ↗
45. Astrocytes: Role and Functions in Brain Pathologies10.3389/fphar.2019.01114 ↗
46. Glial Scar Formation Occurs in the Human Brain after Ischemic Stroke10.7150/ijms.8140 ↗
47. Immune function of astrocytes10.1002/glia.1107 ↗
48. Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases10.1007/s13311-016-0477-8 ↗
49. Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke10.1016/j.pneurobio.2015.09.008 ↗
50. The Multifaceted Profile of Activated Microglia10.1007/s12035-009-8077-9 ↗
51. Microglia: Neuroprotective and neurotrophic cells in the central nervous system10.2174/1568006043481284 ↗
52. Ji, K., Akgul, G., Wollmuth, L.P., and Tsirka, S.E. (2013). Microglia Actively Regulate the Number of Functional Synapses. PLoS ONE, 8.10.1371/journal.pone.0056293 ↗
53. Glial Cells: Role of the Immune Response in Ischemic Stroke10.3389/fimmu.2020.00294 ↗
54. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy10.1038/nature24016 ↗
55. Glioblastoma niches: From the concept to the phenotypical reality10.1007/s10072-018-3408-0 ↗
56. Microglial activation and progressive brain changes in schizophrenia10.1111/bph.13364 ↗
57. Oligodendrocytes and Ischemic Brain Injury10.1097/01.WCB.0000053472.41007.F9 ↗
58. Oligodendrogenesis after cerebral ischemia10.3389/fncel.2013.00201 ↗
59. Remyelination after spinal cord injury: Is it a target for repair?10.1016/j.pneurobio.2014.02.006 ↗
60. Oligodendrogenesis in the normal and pathological central nervous system
61. Extracellular matrix in the CNS10.1212/WNL.0000000000002044 ↗
62. Matrix metalloproteinases as therapeutic targets for stroke10.1016/j.brainres.2015.04.024 ↗
63. Stroke Repair via Biomimicry of the Subventricular Zone10.3389/fmats.2018.00015 ↗
64. Brain keratan sulfate and glial scar formation10.1196/annals.1377.014 ↗
65. Targeting the neural extracellular matrix in neurological disorders10.1016/j.neuroscience.2013.08.050 ↗
66. Neuroprotection and repair in multiple sclerosis10.1038/nrneurol.2012.200 ↗
67. Integrin-linked kinase is required for laminin-2-induced oligodendrocyte cell spreading and CNS myelination10.1083/jcb.200304154 ↗
68. The extracellular matrix in multiple sclerosis pathology10.1111/j.1471-4159.2007.04897.x ↗
69. Fibronectin aggregation in multiple sclerosis lesions impairs remyelination10.1093/brain/aws313 ↗
70. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation10.1038/nm1279 ↗
71. Chondroitin Sulfate Proteoglycans in Demyelinated Lesions Impair Remyelination10.1002/ana.23599 ↗
72. Persistent decrease in multiple components of the perineuronal net following status epilepticus10.1111/j.1460-9568.2012.08268.x ↗
73. Role of hyaluronan in glioma invasion10.4161/cam.2.3.6320 ↗
74. The Pathobiology of Collagens in Glioma10.1158/1541-7786.MCR-13-0236 ↗
75. Extracranial primitive neuroectodermal tumours. The Memorial Sloan-Kettering Cancer Center experience10.1002/1097-0142(19910401)67:7<1825::AID-CNCR2820670702>3.0.CO;2-3 ↗
76. Heparan sulfate in the regulation of neural differentiation and glioma development10.1111/febs.13097 ↗
77. In vitro Models of Neurodegenerative Diseases10.3389/fcell.2020.00328 ↗
78. In silico modelling of physiologic systems10.1016/j.bpa.2011.08.006 ↗
79. Destexhe, A. (2021). In Silico, Computer Simulations from Neurons up to the Whole Brain. Eneuro, 8.10.1523/ENEURO.0124-21.2021 ↗
80. State of the art paper 2D and 3D cell cultures-a comparison of different types of cancer cell cultures
81. A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity10.1016/j.pharmthera.2012.01.001 ↗
82. Carter, M., and Shieh, J. (2015). Chapter 14—Cell Culture Techniques. Guide to Research Techniques in Neuroscience, Academic Press. [2nd ed.].10.1016/B978-0-12-800511-8.00014-9 ↗
83. In vitro models for the prediction of in vivo performance of oral dosage forms
84. In vivo models of primary brain tumors: Pitfalls and perspectives10.1093/neuonc/nos135 ↗
85. In vivo animal models for studying brain metastasis: Value and limitations10.1007/s10585-013-9566-9 ↗
86. Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemia10.1016/j.neuropharm.2012.12.001 ↗
87. Toward in vitro models of brain structure and function10.1073/pnas.1414484111 ↗
88. (2010, October 20). Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the Protection of Animals Used for Scientific Purposes. Available online: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:276:0033:0079:en:PDF.
89. An in vitro model of traumatic brain injury utilising two-dimensional stretch of organotypic hippocampal slice cultures10.1016/j.jneumeth.2005.06.014 ↗
90. 2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling10.1186/s13024-018-0258-4 ↗
91. 3D in vitro modeling of the central nervous system10.1016/j.pneurobio.2014.11.003 ↗
92. Agostinho Machado-Neto, J., Lima, K., Marconi Roversi, F., Suchorska, W.M., Richter, M., Piwocka, O., Musielak, M., Piotrowski, I., and Trzeciak, T. (2021). From Donor to the Lab: A Fascinating Journey of Primary Cell Lines. Front. Cell. Dev. Biol., 9.10.3389/fcell.2021.711381 ↗
93. Ferrari, E., Cardinale, A., Picconi, B., and Gardoni, F. (2020). From cell lines to pluripotent stem cells for modelling Parkinson’s Disease. J. Neurosci. Methods., 340.10.1016/j.jneumeth.2020.108741 ↗
94. Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology10.1007/978-1-62703-640-5_2 ↗
95. SH-SY5Y human neuroblastoma cell line: In vitro cell model of dopaminergic neurons in Parkinson’s disease
96. Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line10.1007/s11033-020-05925-2 ↗
97. Development of a Neural Phenotype in Differentiating Ganglion Cell-Derived Human Neuroblastoma Cells10.1002/jcp.1041280221 ↗
98. Dibutyryl cyclic AMP induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic phenotype10.1016/j.neulet.2008.07.079 ↗
99. Sequential Treatment of SH-SY5Y Cells with Retinoic Acid and Brain-Derived Neurotrophic Factor Gives Rise to Fully Differentiated, Neurotrophic Factor-Dependent, Human Neuron-Like Cells10.1046/j.1471-4159.2000.0750991.x ↗
100. Cholesterol supports the retinoic acid-induced synaptic vesicle formation in differentiating human SH-SY5Y neuroblastoma cells10.1111/j.1471-4159.2007.04676.x ↗